No Data
14 Out of 18 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Amgen, AstraZeneca Post Phase 3 Win for Nasal Polyps Therapy
Coherus Stock Rallies 19% on Q3 Earnings, Udenyca Production Update
Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?
BMO Capital Maintains Outperform on Gilead Sciences, Raises Price Target to $102